Type
Internal restructuring
Country
France
Region
Location of affected unit(s)
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

670 - 750 jobs
Number of planned job losses
Job loss
250 jobs
Number of planned job creations
Job creation
Announcement Date
5 December 2018
Employment effect (start)
9 December 2018
Foreseen end date
31 December 2020

Description

The pharmaceutical group Sanofi has announced a reorganisation plan to remove 670 jobs in France by the end of 2020, as part of a new global transformation plan. Job cuts must be made in three different entities: 70 in the Research and Development department; 30 at Sanofi-Pasteur and 570 at Sanofi Aventis Group. In addition to these 570 job cuts at Sanofi-Aventis, there are 80 transfers of IT jobs to a US subcontractor, Cognizant. If employees refuse to be transferred to this provider, the number of job cuts may be higher.

Voluntary departures would be carried out through a new mechanism put in place by the labour law reform of 2017: a procedure called 'collective conventional termination' (rupture conventionnelle collective). The workers' representatives firmly expressed their concern and disappointment about the appplication of this procedure.

In addition, the first French pharmaceutical laboratory wants to recruit 250 people, still in France, but for new positions in bioproducts or digital areas. The total job losses will then be reduced to 420 to 500 (taking into account transfer refusals). 


Sources

Citation

Eurofound (2018), Sanofi, Internal restructuring in France, factsheet number 96043, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/96043.